DNase I treatment or Padi4 gene deficiency abolishes NETs formation in the intestinal epithelium and mitigates intestinal epithelial barrier impairment in the hyperglycemic mice, supporting the causal relationship between NETs and hyperglycemia-associated intestinal epithelial barrier impairment. Here, PADI4 is linked to Hyperglycemia.